'Mad Money' Lightning Round: Teva's Way Too Hard to Own
NEW YORK (TheStreet) -- Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Friday night:
Solazyme (SZYM) : "No, that's too speculative for me."
Allot Communications (ALLT) : "At this level I don't want to sell it, it's too low."
Teva Pharmaceutical (TEVA) : "Enough of that one. It's way too hard to own."
Energy Transfer Partners (ETP) : "Listen up. If they do another equity offering they're going on my Wall of Shame. That's the worst-performing stock in my charitable trust."To read a full recap of "Mad Money" on CNBC, click here.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
-- Written by Scott Rutt in Washington, D.C.
To email Scott about this article, click here: Scott Rutt